1.
Sillito F, Rampotas A, Cheok K, Pomplun S, Baker R, Marafioti T, O’Reilly M, Gupta R, Kirkwood AA, Roddie C. Clonal evolution and the risk of secondary myeloid neoplasia following chimeric antigen receptor T-cell therapy. Haematologica 2025;110(11):2812-2818; https://doi.org/10.3324/haematol.2025.287341.